Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
RLMD
RLMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest RLMD ETF News Today | Earnings, Events & Price Alerts
RLMD News
Helus Pharma's Psychedelic Drug Achieves Phase 3 Success
5d ago
PRnewswire
Helus Pharma Achieves Breakthrough in Depression Treatment
5d ago
Newsfilter
BTIG Initiates Buy Rating on Invivyd Inc with $10 Price Target
Dec 22 2025
Benzinga
Relmada Therapeutics Sets Price for $100 Million Underwritten Common Stock and Pre-Funded Warrant Offering
Nov 04 2025
Newsfilter
Relmada Receives FDA Feedback Endorsing Two Distinct Acceptable Pathways for NDV-01 Registration Studies in Non-Muscle Invasive Bladder Cancer
Nov 04 2025
Newsfilter
Relmada Therapeutics Welcomes Renowned Urologic Oncologist Max Kates, MD, to Clinical Advisory Board for NDV-01 Development
Oct 07 2025
Newsfilter
Insider Buying Update for Tuesday, September 2: RLMD, STRA
Sep 02 2025
NASDAQ.COM
Relmada outlines 2026 trial launches for NDV-01 and sepranolone as pipeline advances
Aug 08 2025
SeekingAlpha
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket
Jul 22 2025
Benzinga
Relmada Therapeutics Appoints Renowned Urologic Oncologist, Yair Lotan, MD, to Chair the Clinical Advisory Board and Support Development of NDV-01
Jul 15 2025
Newsfilter
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
Jun 17 2025
Newsfilter
Relmada Therapeutics Hires Raj S. Pruthi As Chief Medical Officer-Urology
Jun 17 2025
NASDAQ.COM
Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
May 08 2025
Newsfilter
Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025
Apr 28 2025
Newsfilter
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
Apr 27 2025
Yahoo Finance
Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data
Apr 24 2025
Newsfilter
Show More News
